Clinical Trial Update: Efficacy and Safety Study of HS-25 in Chinese Adults With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of HS-25 in Chinese adults with primary hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• HS-25

Snippet

Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd. | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED